Citation Impact
Citing Papers
Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys
2010
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses
2012
Comprehensive Assessment of HIV Target Cells in the Distal Human Gut Suggests Increasing HIV Susceptibility Toward the Anus
2013
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
The Epidemiology of Obesity: A Big Picture
2014 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
2008
Vector-Mediated Antibody Gene Transfer for Infectious Diseases
2015
Is Obesity a Risk Factor for Vaccine Non-Responsiveness?
2013
The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors
2010
Targeting early infection to prevent HIV-1 mucosal transmission
2010 Nature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
2013
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Weighing the gold in the gold standard: challenges in HIV prevention research
2010
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Cancer immunotherapy via dendritic cells
2012 Standout
Successes and challenges of HIV prevention in men who have sex with men
2012
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
2010
Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach
2011
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Synthetic DNA vaccine strategies against persistent viral infections
2013
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
2018 Standout
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Seroadaptive Practices: Association with HIV Acquisition among HIV-Negative Men Who Have Sex with Men
2012
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
Host Genetic Determinants of T Cell Responses to the MRKAd5 HIV-1 gag/pol/nef Vaccine in the Step Trial
2011
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials
2011
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
2009
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial
2010
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Worldwide burden of HIV in transgender women: a systematic review and meta-analysis
2012 Standout
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
2022
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Microbicides and HIV prevention: lessons from the past, looking to the future
2009
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Pre-erythrocytic malaria vaccines: identifying the targets
2012
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Selectively willing and conditionally able: HIV vaccine trial participation among women at “high risk” of HIV infection
2011
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Addressing Research Priorities for Prevention of HIV Infection in the United States
2010
Nucleoside Modified mRNA Vaccines for Infectious Diseases
2016 StandoutNobel
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
2010 StandoutNobel
Is developing an HIV-1 vaccine possible?
2010
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
2009
AAV Vectors Vaccines Against Infectious Diseases
2014
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses
2011
Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
2014
Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions
2014
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
2010
Control of adaptive immunity by the innate immune system
2015 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Male circumcision for prevention of homosexual acquisition of HIV in men
2011
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
2019 Standout
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
2011 StandoutScienceNobel
Pre-existing immunity against Ad vectors
2014
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8 + T-Cell Responses in Rhesus Macaques
2010
Inhibition of DC-SIGN-Mediated HIV Infection by a Linear Trimannoside Mimic in a Tetravalent Presentation
2010
HIV-1 Vaccine Development After STEP
2010
The oral mucosa immune environment and oral transmission of HIV /SIV
2013
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
DNA Immunization for HIV Vaccine Development
2014
Tissue‐resident memory T cells
2013
DNA vaccines: an historical perspective and view to the future
2010
Male circumcision for prevention of heterosexual acquisition of HIV in men
2009 Standout
A Systematic Review of Barriers and Facilitators to Minority Research Participation Among African Americans, Latinos, Asian Americans, and Pacific Islanders
2013 Standout
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
2015
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
CD40‐targeted adenoviral cancer vaccines: the long and winding road to the clinic
2012
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Early identification of antigen-specific immune responses in vivo by [ 18 F]-labeled 3′-fluoro-3′-deoxy-thymidine ([ 18 F]FLT) PET imaging
2011
Progress toward active or passive HIV-1 vaccination
2016
RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
2011 StandoutNobel
Polyvalent vaccine approaches to combat HIV ‐1 diversity
2017
Works of David Li being referenced
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout